Accessibility Menu
 
Nyxoah logo

Nyxoah

(NASDAQ) NYXH

Current Price$2.80
Market Cap$123.13M
Since IPO (2021)-88%
5 YearN/A
1 Year-65%
1 Month-37%

Nyxoah Financials at a Glance

Market Cap

$123.13M

Revenue (TTM)

$10.02M

Net Income (TTM)

$90.08M

EPS (TTM)

$-2.67

P/E Ratio

-1.06

Dividend

$0.00

Beta (Volatility)

0.49 (Low)

Price

$2.80

Volume

6,169

Open

$2.97

Previous Close

$2.80

Daily Range

$2.78 - $2.97

52-Week Range

$2.77 - $8.64

NYXH News

NYXH: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nyxoah

Industry

Healthcare Equipment and Supplies

Employees

153.7

CEO

Olivier Taelman, EMBA

Headquarters

Mont-Saint-Guibert, 1435, BE

NYXH Financials

Key Financial Metrics (TTM)

Gross Margin

63%

Operating Margin

-8%

Net Income Margin

-9%

Return on Equity

-116%

Return on Capital

-1%

Return on Assets

-76%

Earnings Yield

-94.34%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$123.13M

Shares Outstanding

43.66M

Volume

6.17K

Short Interest

0.00%

Avg. Volume

56.04K

Financials (TTM)

Gross Profit

$6.32M

Operating Income

$84.73M

EBITDA

$84.73M

Operating Cash Flow

$49.23M

Capital Expenditure

$6.07M

Free Cash Flow

$55.30M

Cash & ST Invst.

$47.98M

Total Debt

$42.06M

Nyxoah Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$5.64M

+346.7%

Gross Profit

$3.62M

+290.5%

Gross Margin

64.23%

N/A

Market Cap

$123.13M

N/A

Market Cap/Employee

$672.83K

N/A

Employees

183

N/A

Net Income

$23.50M

-37.1%

EBITDA

$19.73M

-33.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$5.92M

-90.6%

Accounts Receivable

$7.72M

+128.3%

Inventory

$4.66M

-1.2%

Long Term Debt

$18.30M

-14.0%

Short Term Debt

$23.76M

+1639.4%

Return on Assets

-76.06%

N/A

Return on Invested Capital

-1.22%

N/A

Free Cash Flow

$20.51M

-44.3%

Operating Cash Flow

$20.48M

-52.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
STIMNeuronetics, Inc.
$1.29-3.01%
OABIOmniAb, Inc.
$1.51-4.43%
IVVDInvivyd, Inc.
$1.37-9.27%
TARAProtara Therapeutics, Inc.
$4.94-4.82%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About NYXH

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.